Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $-36.50M.
ENTERPRISE VALUE (EV)
$-36.50M
Context Therapeutics Inc.
Market Cap
$29.49M
Enterprise Value (EV)
$-36.50M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Context Therapeutics Inc. (CNTX) | $29.49M | $-36.50M |
| Quantum Cyber N.V. (QUCY)vs › | $29.48M | $16.28M |
| GridAI Technologies Corp. (GRDX)vs › | $29.81M | $30.24M |
| OneMedNet Corporation (ONMD)vs › | $29.16M | $29.50M |
| CervoMed Inc. (CRVO)vs › | $30.09M | $7.63M |
| Tevogen Bio Holdings Inc. (TVGN)vs › | $28.86M | $30.82M |
| MIRA Pharmaceuticals, Inc. (MIRA)vs › | $30.26M | $26.65M |
| MDxHealth S.A. (MDXH)vs › | $30.61M | $117.25M |
| SCYNEXIS, Inc. (SCYX)vs › | $30.72M | $22.18M |
| Baird Medical Investment Holdings Limited (BDMD)vs › | $30.85M | $44.79M |
Market Cap
$29.49M
Total Debt
$0.00
Cash
$66.00M
Enterprise Value
$-36.50M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
